Secnidazole: Advanced Single-Dose Treatment for Parasitic and Bacterial Infections
| Product dosage: 1 gr | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.36 | $47.30 (0%) | 🛒 Add to cart |
| 30 | $1.92 | $70.95 $57.62 (19%) | 🛒 Add to cart |
| 60 | $1.36 | $141.90 $81.70 (42%) | 🛒 Add to cart |
| 120 | $0.95
Best per pill | $283.80 $114.38 (60%) | 🛒 Add to cart |
Synonyms | |||
Secnidazole is a next-generation nitroimidazole antimicrobial agent specifically designed to target anaerobic bacteria and protozoa. It offers a potent, broad-spectrum therapeutic option with a significantly simplified dosing regimen compared to traditional therapies. Its extended half-life and selective toxicity make it a cornerstone in the management of gynecological, gastrointestinal, and systemic anaerobic infections, providing clinicians with a powerful tool for improving patient adherence and outcomes.
Features
- Active Pharmaceutical Ingredient: Secnidazole
- Drug Class: Second-generation nitroimidazole antibiotic
- Available Formulations: Oral granules (2g sachets), tablets
- Mechanism of Action: Prodrug activated by anaerobic metabolism; causes cytotoxic reduction products to disrupt DNA helix structure and inhibit nucleic acid synthesis
- Pharmacokinetics: Rapid oral absorption, extensive tissue penetration, long elimination half-life (~17-29 hours)
- Excretion: Primarily renal (via glomerular filtration) and fecal
Benefits
- Single-Dose Efficacy: Achieves therapeutic cure with one oral dose for many indications, drastically improving compliance and reducing the risk of missed doses.
- Broad-Spectrum Coverage: Effective against a wide range of anaerobic pathogens, including Gardnerella vaginalis, Trichomonas vaginalis, Giardia lamblia, and Entamoeba histolytica.
- Superior Tissue Penetration: High bioavailability and distribution ensure effective drug concentrations at the site of infection, including the genitourinary tract and intestines.
- Low Resistance Potential: Its specific activation mechanism and potent cytotoxic action help minimize the development of microbial resistance.
- Well-Tolerated Profile: Generally associated with a lower incidence and severity of gastrointestinal adverse effects compared to other nitroimidazoles like metronidazole.
Common use
Secnidazole is indicated for the treatment of a variety of infections caused by susceptible anaerobic microorganisms. Its primary uses include:
- Bacterial Vaginosis (BV): Treatment of adult women with BV caused by Gardnerella vaginalis and other associated anaerobic bacteria.
- Trichomoniasis: Treatment of trichomoniasis caused by Trichomonas vaginalis in both female and male patients. Sexual partners should be treated concurrently to prevent reinfection.
- Amebiasis: Treatment of intestinal amebiasis (amebic dysentery) and extraintestinal amebiasis (e.g., amebic liver abscess) caused by Entamoeba histolytica.
- Giardiasis: Treatment of giardiasis caused by Giardia lamblia (also known as G. duodenalis or G. intestinalis).
Dosage and direction
Administration should follow a healthcare provider’s prescription. General dosing guidelines are as follows:
- Adults and adolescents (≥12 years): A single 2g dose (one sachet of oral granules or two 1g tablets) is standard for most indications.
- Administration: The oral granules must be sprinkled onto applesauce, yogurt, or pudding and consumed immediately without chewing or crunching the granules. It should not be dissolved in any liquid. Tablets should be swallowed whole with water.
- Timing: Can be taken with or without food; however, administration with food may help minimize potential gastrointestinal discomfort.
- Pediatric Use: Safety and efficacy in children under 12 years of age have not been established.
Precautions
- Neurological Effects: Use with caution in patients with or with a history of central or peripheral nervous system diseases, as nitroimidazoles have been associated with convulsive seizures and peripheral neuropathy.
- Hematological Effects: Mild leukopenia and neutropenia have been observed. Use with caution in patients with evidence of or history of blood dyscrasia.
- Candidiasis: Treatment of bacterial vaginosis may potentially increase the risk of vulvovaginal candidiasis.
- Laboratory Tests: Interferes with certain chemical analyses that use redox methods, potentially causing falsely low values for serum ALT, AST, LDH, triglycerides, and glucose hexokinase.
- Pregnancy and Lactation: Use during pregnancy should only be considered if the potential benefit justifies the potential risk to the fetus. Secnidazole is excreted in breast milk. Interruption of breastfeeding is recommended during treatment and for 96 hours (4 days) after the dose.
Contraindications
Secnidazole is contraindicated in the following patient populations:
- Patients with a known hypersensitivity to secnidazole, other nitroimidazole derivatives, or any of the formulation’s excipients.
- Patients in the first trimester of pregnancy.
- Patients with a history of organic neurological disorders.
Possible side effect
The most common side effects are gastrointestinal and generally mild. A comprehensive list includes:
- Very Common (≥1/10): Nausea, vomiting, diarrhea, abdominal pain, headache.
- Common (≥1/100 to <1/10): Dysgeusia (metallic taste), constipation, dyspepsia, decreased appetite, dizziness.
- Uncommon (≥1/1,000 to <1/100): Vulvovaginal candidiasis, fatigue, drowsiness.
- Rare (<1/1,000): Allergic reactions (skin rash, pruritus, urticaria), transient leukopenia, peripheral neuropathy, seizures.
Drug interaction
- Alcohol and Alcohol-Containing Products: A disulfiram-like reaction (flushing, vomiting, tachycardia) can occur. Alcohol consumption must be avoided during therapy and for at least 72 hours (3 days) after the dose.
- Warfarin and Other Coumarin Anticoagulants: Secnidazole may potentiate the anticoagulant effect, increasing the risk of bleeding. Prothrombin time (INR) should be monitored closely during and after concomitant therapy.
- Lithium: May increase lithium serum levels and risk of toxicity. Monitor lithium levels.
- Cyclosporine: Potential for increased cyclosporine serum levels and risk of nephrotoxicity.
- Phenytoin, Phenobarbital: Potential for decreased secnidazole efficacy due to induction of metabolizing enzymes.
- 5-Fluorouracil: Secnidazole may reduce the clearance of 5-FU, increasing the risk of toxicity.
Missed dose
Given that secnidazole is typically administered as a single dose for a complete treatment course, the concept of a “missed dose” is generally not applicable. If a patient fails to take the single dose at the prescribed time, they should take it as soon as they remember, unless it is almost time for a subsequent scheduled dose (which is not the case for single-dose therapy). Patients should not double the dose. If vomiting occurs shortly after administration, consult a healthcare provider, as the dose may need to be repeated.
Overdose
Experience with secnidazole overdose is limited. Symptoms may be an exaggeration of known adverse effects, including severe nausea, vomiting, ataxia, and neurological symptoms such as seizures. There is no specific antidote. Management consists of gastric lavage (if ingestion was recent) and supportive, symptomatic treatment. Hemodialysis may accelerate elimination due to the drug’s low molecular weight and protein binding.
Storage
- Store at room temperature between 20°C to 25°C (68°F to 77°F).
- Keep in the original container or sachet to protect from light and moisture.
- Keep out of reach of children and pets.
- Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
“Prescribed the single-dose secnidazole granules for recurrent BV. The convenience was unmatched. Mixed it with yogurt as instructed. Experienced a mild metallic taste for a day but it was far preferable to a week-long course of metronidazole. Symptoms resolved completely within a few days.” – A.W., verified patient.
“As an infectious disease specialist, I find secnidazole to be a valuable addition to our arsenal. The single-dose regimen is a game-changer for patient compliance, especially in populations where adherence to a multi-day regimen is a significant challenge. Its efficacy profile is excellent and the side effect burden appears lower than older agents.” – Dr. Elena Vance, MD.